These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 22629356)
1. Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence. Satti H; McLaughlin MM; Omotayo DB; Keshavjee S; Becerra MC; Mukherjee JS; Seung KJ PLoS One; 2012; 7(5):e37114. PubMed ID: 22629356 [TBL] [Abstract][Full Text] [Related]
6. Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India. Isaakidis P; Paryani R; Khan S; Mansoor H; Manglani M; Valiyakath A; Saranchuk P; Furin J PLoS One; 2013; 8(7):e68869. PubMed ID: 23894358 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania. Mpagama SG; Heysell SK; Ndusilo ND; Kumburu HH; Lekule IA; Kisonga RM; Gratz J; Boeree MJ; Houpt ER; Kibiki GS PLoS One; 2013; 8(5):e62034. PubMed ID: 23675411 [TBL] [Abstract][Full Text] [Related]
8. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care. Brust JC; Shah NS; Scott M; Chaiyachati K; Lygizos M; van der Merwe TL; Bamber S; Radebe Z; Loveday M; Moll AP; Margot B; Lalloo UG; Friedland GH; Gandhi NR Int J Tuberc Lung Dis; 2012 Aug; 16(8):998-1004. PubMed ID: 22668560 [TBL] [Abstract][Full Text] [Related]
9. Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria. Oladimeji O; Isaakidis P; Obasanya OJ; Eltayeb O; Khogali M; Van den Bergh R; Kumar AM; Hinderaker SG; Abdurrahman ST; Lawson L; Cuevas LE PLoS One; 2014; 9(4):e94393. PubMed ID: 24722139 [TBL] [Abstract][Full Text] [Related]
10. Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India. Isaakidis P; Varghese B; Mansoor H; Cox HS; Ladomirska J; Saranchuk P; Da Silva E; Khan S; Paryani R; Udwadia Z; Migliori GB; Sotgiu G; Reid T PLoS One; 2012; 7(7):e40781. PubMed ID: 22792406 [TBL] [Abstract][Full Text] [Related]
11. Malnutrition associated with unfavorable outcome and death among South African MDR-TB and HIV co-infected children. Hicks RM; Padayatchi N; Shah NS; Wolf A; Werner L; Sunkari VB; O'Donnell MR Int J Tuberc Lung Dis; 2014 Sep; 18(9):1074-83. PubMed ID: 25189555 [TBL] [Abstract][Full Text] [Related]
12. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study. Fairlie L; Beylis NC; Reubenson G; Moore DP; Madhi SA BMC Infect Dis; 2011 Jan; 11():28. PubMed ID: 21269475 [TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis. Chem ED; Van Hout MC; Hope V BMC Infect Dis; 2019 Aug; 19(1):723. PubMed ID: 31420021 [TBL] [Abstract][Full Text] [Related]
14. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa. Umanah TA; Ncayiyana JR; Nyasulu PS Trans R Soc Trop Med Hyg; 2015 May; 109(5):340-8. PubMed ID: 25787727 [TBL] [Abstract][Full Text] [Related]
15. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan. van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387 [TBL] [Abstract][Full Text] [Related]
16. Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa. Seung KJ; Omatayo DB; Keshavjee S; Furin JJ; Farmer PE; Satti H PLoS One; 2009 Sep; 4(9):e7186. PubMed ID: 19779624 [TBL] [Abstract][Full Text] [Related]
17. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana. Hafkin J; Modongo C; Newcomb C; Lowenthal E; MacGregor RR; Steenhoff AP; Friedman H; Bisson GP Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297 [TBL] [Abstract][Full Text] [Related]
18. High treatment success rate among multidrug-resistant tuberculosis patients in Myanmar, 2012-2014: a retrospective cohort study. Thu MK; Kumar AMV; Soe KT; Saw S; Thein S; Mynit Z; Maung HMW; Aung ST Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):410-417. PubMed ID: 29351672 [TBL] [Abstract][Full Text] [Related]
19. Factors associated with unfavorable treatment outcomes among multidrug-resistant tuberculosis patients, Sierra Leone: a cross-sectional secondary data analysis. Koroma JA; Elduma AH; Sesay U; Gebru GN BMC Infect Dis; 2024 Jun; 24(1):579. PubMed ID: 38862873 [TBL] [Abstract][Full Text] [Related]
20. High treatment success in children treated for multidrug-resistant tuberculosis: an observational cohort study. Seddon JA; Hesseling AC; Godfrey-Faussett P; Schaaf HS Thorax; 2014 May; 69(5):458-64. PubMed ID: 24064441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]